This account has been archived, please follow @IP_London for future #IP2ATLANTA updates
Imperial College London
Joined June 2019
- Tweets112
- Following420
- Followers167
- Likes194
Pinned Tweet
📢 Our clinical trial accounts are being archived - please follow @IP_London for future #IP2ATLANTA updates
#UrSoMe
🍾Really great effort from all the @MatterTrial @IP_London trials team.
As options for cytoreductive treatments increase this is the first study to determine if patients with mHSPC are willing to accept the potentialeffect sizes reported.
We look forward to the results!
👋IP5-MATTER trial protocol published in @BMJ_Open this week.
Recruiting in 30 NHS centres-ahead of schedule, results due in 2022.
Congrats to the huge UK effort @IP_London @HERU_Abdn @VWatsonEcon @Connor_Urol @LondonProstate1 @wellcometrust
bmjopen.bmj.com/content/11/1…
IP2 - ATLANTA Trial retweeted
Check out the full text FREE here --> urologynews.uk.com/features/…
@Uro_News @AtlantaIp2 @MatterTrial
IP2 - ATLANTA Trial retweeted
Well done Martin on a nice article summarising trials in cytoreductive surgery in metastatic prostate cancer in @Uro_News
@IP_London
@timdudderidge
@stingrai78
@Connor_Urol
@SageOfLondon1
@AtlantaIp2 @MatterTrial
A massive well done to our team in Southampton who are the top recruiters for IP2-Atlanta with 40 patients! Amazing! @timdudderidge @londonprostate1 @IP_London @wellcometrust
A big welcome to IP2-ATLANTA for the Clatterbridge Cancer Centre who have already randomised their first patient! Great to have you with us!
@CCCNHS @londonprostate1 @IP_London @wellcometrust
Incredible work by our top recruiting site in September. A huge well done to the team at the Royal Devon and Exeter NHS Trust for recruiting 4 patients last month!
@pelvicERAS @londonprostate1 @IP_London @wellcometrust
👏👏👏
IP2 - ATLANTA Trial retweeted
A huge congratulations to our top recruiter in September for IP-5 Matter.
Well done East Surrey Hospital for recruiting 4 patients! Amazing work!
@connor_urol @londonprostate1 @uclhcharity @wellcome @IP_London
👏👏👏
IP2 - ATLANTA Trial retweeted
MRI findings in de novo synchronous metastatic prostate cancer - what are the implications for cytoreductive prostatectomy?
Sad not to be able to give this #Podium session at #AUA21 in Las Vegas, but honoured to be able to present my early PhD work virtually
@AmerUrological
Huge congratulations to our team in Southampton for being an exceptional recruiter to IP2-Atlanta! Thank you for your hard work! @timdudderidge
IP2 - ATLANTA Trial retweeted
Important paradigm to evaluate in the IP2-ATLANTA RCT with patient trade-offs evaluated in IP5-MATTER
@MatterTrial #EAU21 #EAU2021 @IP_London @AtlantaIp2 @MatterTrial @HERU_Abdn @VWatsonEcon @Connor_Urol @NIHRresearch @NCRI_partners
(3/4) Prof. A. Briganti: “Provided good patient selection & experienced hands, cRP is a possible option for men with oligometastatic PCa within the setting of clinical trial.”
#EAU21 Lecture: “Local treatment: Surgery (primary +/- lymph nodes)”
IP2 - ATLANTA Trial retweeted
Our lead @Connor_Urol presenting IP5-MATTER trial updated at #EAU21.
Open in 22 centres with recruitment ahead of schedule! Thanks to everyone supporting this study -
@wellcometrust @UCLHCharity @LondonProstate1 @IP_London @ImperialSandC @NIHRCRN_NWLdn
virtual.uroweb.org/resource-…
IP2 - ATLANTA Trial retweeted
🔊 🔊 IP5-MATTER Exceeds national recruitment target for the first 3-months !
Massive well done to all our UK NHS sites, especially to the top 3 super recruiters:
1. West Middlesex University Hospital
2. Royal United Hospitals Bath
3. King's Lynn, Cambridge
@IP_London
IP2 - ATLANTA Trial retweeted
Great
UK @AtlantaIp2 RCT chomping at bit to recruit quickly to answer this key question
Nearly 100 randomised
@NCRI_partners @NIHRCRN_NWLdn @NIHRCRN_tvsm @NIHRCRNEastern @NIHRCRN_nwcoast @NIHRCRN_yorks @NIHRCRN_nthames @NIHRCRN_kss @NIHRCRNWessex @NIHRCRNEastMids
@SWOG and NCTN, S1802, “Randomized trial of Standard Systemic Therapy +/- local therapy (surgery or radiation) in M1 PCa is active as of today. Access via CTSU website for protocol documents. Please activate at your site and start enrolling. #PCSM #clinicaltrials
IP2 - ATLANTA Trial retweeted
New @HERU_Abdn blog posted on the IP5-MATTER TRIAL, led by @Connor_Urol @IP_London, and our development of a choice experiment (DCE) to identify the treatment preferences of men with newly diagnosed metastatic prostate cancer @MatterTrial @LondonProstate1 bit.ly/ip5matter
IP2 - ATLANTA Trial retweeted
📢We are very excited to be able to share @MatterTrial progress with you, accepted as a trials-in-progress abstract @Uroweb #EAU21 annual congress!
Congratulations to all the co-authors & funders @wellcometrust @UCLHCharity @HERU_Abdn @Connor_Urol @VWatsonEcon @LondonProstate1
Well done for getting this academic charity funded study open @MatterTrial team!
Great to see @UHSFT offering another prostate cancer study to local patients @NIHRCRNWessex
📢Hugely excited to welcome University Hospital Southampton to the @MatterTrial today under the stewardship of @timdudderidge hard working research unit!
Look forward to offering another advanced prostate cancer study to local patients! @NIHRCRNWessex @unisouthampton @UHSFT
IP2 - ATLANTA Trial retweeted
Cryoablation Plus ADT for Newly Diagnosed Metastatic PCa Improves Outcomes bit.ly/2P9wc7u
IP2 - ATLANTA Trial retweeted
Good strong signal.
To be formally evaluated in MIAT arm (with HIFU) in IP2-ATLANTA RCT.
bmjopen.bmj.com/content/11/2…
@IP_London @AtlantaIp2 @MatterTrial
IP2 - ATLANTA Trial retweeted
New Clinical Senior Lecturer & Consultant Urological Surgeon position at Imperial.
Academic, Focal Therapy and Robotic Surgery.
@IP_London @imperialurology @ImperialSandC
bmj.com/careers/job/133208/c…